Roche Holding reported 11.55B in Operating Profit for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US USD 4.6B 1.31B
Alcon AG ALC:SW USD 205M 5M
Amgen AMGN:US USD 2.23B 508M
Artemis Alpha ATS:LN GBP -26696000 16.49M
AstraZeneca AZN:LN USD 1.25B 706M
Bayer BAYN:GR EUR 1.2B 1.03B
Biogen BIIB:US USD 1.32B 1.37B
Bristol Myers Squibb BMY:US USD 1.94B 528M
Eli Lilly And LLY:US USD 1.84B 159.9M
Fresenius FRE:GR EUR 887M 42M
Fresenius Medical Care FME:GR EUR 471.64M 130.64M
Galapagos GLPG:NA EUR -37578000 38.75M
Genmab GEN:DC DKK 1.93B 684M
Gilead Sciences GILD:US USD 2.27B 570M
GlaxoSmithKline GSK:LN GBP 1.87B 677M
Hikma Pharmaceutical HIK:LN USD 249M 6M
Merck MRK:GR EUR 1.23B 57M
Merk MRK:US USD 3.51B 505M
Novartis NOVN:VX USD 2.17B 60M
Orion ORNBV:FH EUR 245.4M 163.4M
Pfizer PFE:US USD 5.17B 4.24B
Philips PHIA:NA EUR 171M 1.7B
Recordati REC:IM EUR 122.7M 23.57M
Regeneron Pharmaceuticals REGN:US USD 1.22B 113.8M
Roche Holding ROG:VX 11.55B 3.47B